Walleye Capital LLC - EYEPOINT PHARMACEUTICALS INC ownership

EYEPOINT PHARMACEUTICALS INC's ticker is EYPT and the CUSIP is 30233G209. A total of 84 filers reported holding EYEPOINT PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 0.53 and the average weighting 0.4%.

Quarter-by-quarter ownership
Walleye Capital LLC ownership history of EYEPOINT PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2024$3,253,574
-15.8%
373,974
+100.0%
0.01%
-14.3%
Q1 2024$3,864,422
+2413.8%
186,958
+257.5%
0.01%
+250.0%
Q1 2023$153,730
-37.5%
52,289
-25.6%
0.00%
-50.0%
Q4 2022$245,96670,2760.00%
Other shareholders
EYEPOINT PHARMACEUTICALS INC shareholders Q2 2023
NameSharesValueWeighting ↓
Essex Woodlands Management, Inc. 1,551,521$13,498,2334.40%
Cormorant Asset Management, LP 8,325,000$72,427,5004.18%
ORACLE INVESTMENT MANAGEMENT INC 231,857$2,017,1561.88%
Finepoint Capital LP 707,404$6,154,4151.75%
SUVRETTA CAPITAL MANAGEMENT, LLC 5,175,823$45,029,6601.65%
Octagon Capital Advisors LP 1,093,503$9,513,4761.50%
TCG Crossover Management, LLC 922,335$8,024,3150.84%
SUPERSTRING CAPITAL MANAGEMENT LP 37,838$329,1910.42%
Corton Capital Inc. 49,905$434,1740.23%
SILVERARC CAPITAL MANAGEMENT, LLC 100,000$870,0000.20%
View complete list of EYEPOINT PHARMACEUTICALS INC shareholders